Urology is a major area of focus for Ferring.

We are dedicated to providing treatments that improve the quality of life for:

• adults living with nocturia
• children living with bedwetting
• men affected by prostate cancer
• men affected by the symptoms of low levels of testosterone

MINIRIN (desmopressin) is indicated for the treatment of nocturia, and bedwetting in children. Both conditions are usually caused by an overproduction of urine at night, and MINIRIN acts on the kidneys to reduce this. Bedwetting can be traumatic for children, affecting their well-being and their self-esteem. For adults with nocturia, waking up several times a night to urinate can affect quality of sleep, and sleep deprivation affects a patient’s quality of life.

FIRMAGON (degarelix) is a new medication indicated for the treatment of advanced hormone-dependent prostate cancer. Prostate cancer is one of the most common cancers amongst men. It can affect any man but three-quarters of all cases are aged 65 years or older.

TESTIM (testosterone)* is a gel indicated for men with low testosterone. Men with low testosterone may feel tired, have reduced sex drive, put on weight and may be irritable or depressed. Loss of testosterone is most commonly seen in men aged 50-79.


(*TESTIM is a registered trademark of Auxilium Pharmaceuticals, Inc. - Ferring markets TESTIM in Europe under license from Auxilium Pharmaceuticals, Inc.)